Insiders · Profile

Patience David

Chief Financial Officer at TriSalus Life Sciences. Filing since 23 Feb 2026. CIK 0001970009

Company
Date
Role
Action
Shares
Amount
Of holding
15 May 2026
Chief Financial Officer
Bought
7,100
$17.25K
2.6%
23 Feb 2026
Chief Financial Officer
Bought
3,657
$14.99K
1.4%
2 decisions on file.